Ownership history in US BANCORP \DE\ · 10 quarters on record
This page tracks every 13F SEC filing in which US BANCORP \DE\ reported a position in TREACE MED CONCEPTS INC COM (TMCI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 657 | +244 | +59.1% | 0.00% | $4K | $6.71 |
| 2025 Q2 | REDUCED | 413 | -185 | -30.9% | 0.00% | $2K | $5.88 |
| 2025 Q1 | ADDED | 598 | +20 | +3.5% | 0.00% | $5K | $8.39 |
| 2024 Q4 | ADDED | 578 | +269 | +87.1% | 0.00% | $4K | $7.44 |
| 2024 Q3 | REDUCED | 309 | -371 | -54.6% | 0.00% | $2K | $5.80 |
| 2024 Q2 | ADDED | 680 | +268 | +65.0% | 0.00% | $5K | $6.65 |
| 2024 Q1 | ADDED | 412 | +59 | +16.7% | 0.00% | $5K | $13.05 |
| 2023 Q4 | ADDED | 353 | +268 | +315.3% | 0.00% | $5K | $12.75 |
| 2023 Q3 | ADDED | 85 | +67 | +372.2% | 0.00% | $1K | $13.11 |
| 2023 Q1 | INITIATED | 18 | — | — | 0.00% | $453 | $25.19 |
As of 2025 Q4 — sorted by position size